Index -
P/E 86.58
EPS (ttm) 0.19
Insider Own 28.27%
Shs Outstand 284.09M
Perf Week -1.30%
Market Cap 4.75B
Forward P/E 17.70
EPS next Y 0.94
Insider Trans -56.90%
Shs Float 203.78M
Perf Month 6.57%
Enterprise Value 6.72B
PEG 1.25
EPS next Q 0.24
Inst Own 57.52%
Short Float 3.80%
Perf Quarter 6.16%
Income 55.42M
P/S 4.13
EPS this Y 19.55%
Inst Trans 2.65%
Short Ratio 3.54
Perf Half Y 35.85%
Sales 1.15B
P/B 8.62
EPS next Y 12.79%
ROA 1.75%
Short Interest 7.74M
Perf YTD 22.15%
Book/sh 1.94
P/C 15.77
EPS next 5Y 14.13%
ROE 10.86%
52W High 17.78 -6.02%
Perf Year 28.79%
Cash/sh 1.06
P/FCF 41.37
EPS past 3/5Y -27.77% -
ROIC 1.98%
52W Low 9.53 75.34%
Perf 3Y 88.39%
Dividend Est. -
EV/EBITDA 12.24
Sales past 3/5Y 5.71% 7.17%
Gross Margin 52.23%
Volatility 2.30% 2.82%
Perf 5Y -40.32%
Dividend TTM -
EV/Sales 5.84
EPS Y/Y TTM -21.96%
Oper. Margin 35.09%
ATR (14) 0.49
Perf 10Y -
Dividend Ex-Date -
Quick Ratio 2.16
Sales Y/Y TTM 2.67%
Profit Margin 4.82%
RSI (14) 53.21
Recom 1.78
Dividend Gr. 3/5Y - -
Current Ratio 2.38
EPS Q/Q 183.70%
SMA20 1.51%
Beta 1.83
Target Price 18.93
Payout 0.00%
Debt/Eq 4.14
Sales Q/Q 9.05%
SMA50 2.42%
Rel Volume 1.22
Prev Close 16.60
Employees 3000
LT Debt/Eq 4.10
Earnings Nov 04 BMO
SMA200 22.67%
Avg Volume 2.19M
Price 16.71
IPO Nov 20, 2020
Option/Short Yes / Yes
EPS/Sales Surpr. 19.16% 2.52%
Trades
Volume 2,675,531
Change 0.66%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-13-25 Initiated
BMO Capital Markets
Outperform
$19
May-05-25 Upgrade
Goldman
Neutral → Buy
$17
Dec-06-24 Initiated
Goldman
Neutral
$14
May-21-24 Initiated
Piper Sandler
Neutral
$13
Apr-03-24 Upgrade
Citigroup
Neutral → Buy
$18 → $16
Mar-25-24 Upgrade
Jefferies
Hold → Buy
$15 → $15.50
Feb-06-24 Resumed
KeyBanc Capital Markets
Sector Weight
Jun-26-23 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$24
Jan-23-23 Upgrade
JP Morgan
Underweight → Neutral
$6 → $18
Jan-11-23 Upgrade
Wolfe Research
Peer Perform → Outperform
$25
Jan-11-23 Upgrade
Barclays
Underweight → Overweight
$6 → $22
Nov-15-22 Downgrade
Barclays
Equal Weight → Underweight
$6
Oct-05-22 Downgrade
Citigroup
Buy → Neutral
$25 → $9
Sep-26-22 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Sep-21-22 Downgrade
JP Morgan
Overweight → Underweight
$26 → $9
Sep-20-22 Downgrade
Goldman
Buy → Neutral
$9
Jun-09-22 Downgrade
Wolfe Research
Outperform → Peer Perform
$26
Apr-06-22 Initiated
Wolfe Research
Outperform
$26
Mar-03-22 Downgrade
Jefferies
Buy → Hold
$34 → $22
Mar-02-22 Downgrade
Barclays
Overweight → Equal Weight
$24
Show Previous Ratings
Nov-25-25 09:15AM
Nov-06-25 04:37PM
Nov-04-25 04:12PM
09:30AM
08:45AM
07:20AM
Loading…
07:20AM
07:00AM
Nov-03-25 07:25AM
Nov-02-25 10:02PM
Oct-30-25 12:31AM
Oct-21-25 05:13PM
Oct-17-25 12:48AM
Sep-11-25 12:01AM
Sep-08-25 12:37AM
Sep-04-25 12:16PM
04:57PM
Loading…
Sep-03-25 04:57PM
Aug-27-25 09:55AM
Aug-20-25 11:35PM
Aug-15-25 01:31AM
Aug-14-25 12:44AM
Aug-13-25 05:51PM
Aug-11-25 09:47AM
Aug-09-25 03:08AM
Aug-08-25 01:00PM
12:21PM
07:35AM
07:30AM
Aug-07-25 09:15AM
09:15AM
Aug-06-25 11:01PM
06:05PM
Loading…
Aug-05-25 06:05PM
12:37AM
Jul-28-25 07:38AM
Jul-22-25 12:33AM
Jul-21-25 01:16PM
07:06AM
Jul-04-25 12:33AM
Jun-26-25 03:57AM
Jun-20-25 12:01AM
Jun-18-25 07:39AM
Jun-04-25 07:55AM
May-15-25 03:41PM
May-02-25 02:37PM
03:10AM
May-01-25 09:30AM
08:55AM
07:38AM
Apr-30-25 05:50PM
Apr-17-25 05:16PM
Apr-14-25 10:08AM
05:12AM
Apr-08-25 12:34PM
Mar-25-25 07:50AM
Mar-12-25 05:03AM
Mar-04-25 07:00AM
Feb-28-25 04:30AM
(Thomson Reuters StreetEvents)
02:22AM
Feb-27-25 03:45PM
09:30AM
08:40AM
07:15AM
07:00AM
Feb-26-25 08:13AM
07:19AM
Feb-24-25 09:16AM
Feb-18-25 04:30PM
Feb-17-25 08:44AM
Jan-14-25 07:30AM
Jan-12-25 09:25AM
Jan-07-25 04:30PM
Jan-06-25 04:30PM
Dec-18-24 07:00AM
Nov-20-24 09:00AM
Nov-06-24 02:16AM
01:44AM
(Thomson Reuters StreetEvents)
Nov-05-24 01:00PM
10:00AM
08:25AM
07:00AM
Nov-04-24 07:04AM
Oct-29-24 10:01AM
Oct-22-24 04:30PM
Oct-08-24 11:23AM
Sep-14-24 01:53AM
Sep-10-24 03:16PM
(Investor's Business Daily)
Sep-04-24 04:41PM
Aug-05-24 11:10PM
(Thomson Reuters StreetEvents) +7.56%
04:00PM
09:30AM
08:15AM
07:28AM
07:00AM
Aug-01-24 07:00AM
Jul-22-24 05:00PM
Jun-26-24 06:33AM
May-30-24 05:12PM
May-21-24 09:32AM
08:06AM
07:42AM
May-04-24 09:28AM
Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Michael B. Petras, Jr. Chairman, CEO Dec 08 '25 Proposed Sale 16.75 750,000 12,562,500 Dec 08 05:11 PM WARBURG PINCUS & CO. Director Dec 03 '25 Sale 16.33 9,720,000 158,727,600 34,102,952 Dec 05 08:47 PM WARBURG PINCUS & CO. Director Dec 03 '25 Sale 16.33 9,720,000 158,727,600 34,102,952 Dec 05 08:43 PM GTCR INVESTMENT XI LLC Director Dec 03 '25 Sale 16.33 6,480,000 105,818,400 22,735,301 Dec 05 08:10 PM GTCR FUND XI/C LP Owner Dec 03 '25 Proposed Sale 16.33 1,295,747 21,159,549 Dec 04 06:01 AM GTCR CO-INVEST XI LP Owner Dec 03 '25 Proposed Sale 16.33 41,219 673,106 Dec 03 09:59 PM GTCR FUND XI/A LP Owner Dec 03 '25 Proposed Sale 16.33 5,143,033 83,985,729 Dec 03 09:59 PM WARBURG PINCUS LLC Affiliate Dec 03 '25 Proposed Sale 16.84 9,720,000 163,684,800 Dec 03 08:53 PM GTCR INVESTMENT XI LLC Director Nov 10 '25 Sale 15.65 12,000,000 187,812,000 29,215,301 Nov 12 05:06 PM WARBURG PINCUS & CO. Director Nov 10 '25 Sale 15.65 18,000,000 281,718,000 43,822,952 Nov 12 04:18 PM WARBURG PINCUS & CO. Director Nov 10 '25 Sale 15.65 18,000,000 281,718,000 43,822,952 Nov 12 04:11 PM WARBURG PINCUS & CO. Director Sep 05 '25 Sale 15.11 12,000,000 181,332,000 61,822,952 Sep 09 09:41 PM WARBURG PINCUS & CO. Director Sep 05 '25 Sale 15.11 12,000,000 181,332,000 61,822,952 Sep 09 09:37 PM GTCR INVESTMENT XI LLC Director Sep 05 '25 Sale 15.11 8,000,000 120,888,000 41,215,301 Sep 09 08:41 PM Rutz Michael P President of Sterigenics Aug 22 '25 Sale 16.38 126,611 2,074,306 450,204 Aug 26 06:08 PM Rutz Michael P Officer Aug 22 '25 Proposed Sale 16.12 126,611 2,040,969 Aug 22 10:46 AM